Labocanna Spolka Akcyjna Logo

Labocanna Spolka Akcyjna

Cultivates, produces, and distributes hemp products for food and medical use.

LCN | WAR

Overview

Corporate Details

ISIN(s):
PLCCTLS00017 (+1 more)
LEI:
259400GAPNZTGIR9PK55
Country:
Poland
Address:
KOSZALIN MIESZKA I 49, 75-129 KOSZALIN

Description

Labocanna Spolka Akcyjna is a company engaged in the cultivation, production, and distribution of hemp products. Its offerings include food and medical hemp-derived items. The company's primary strategic goal is to launch the production of medical marijuana for patients and clinical use, with a focus on indoor cultivation methods. Labocanna is pursuing collaborations with research institutes to produce pharmaceutical raw materials and is actively developing new compounds and mixtures based on cannabinoids such as CBD, CBG, and CBC. The company plans to manage 500 hectares of cultivation fields through acquisitions and contracting.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-02-09 17:33
Zawarcie przedwstępnej umowy na import marihuany medycznej - Content (PL)
Polish 2.3 KB
2024-02-09 08:40
Rozwiązanie Umowy Inwestycyjnej w sprawie połączenia ze spółką Foxbuy.com S.A. …
Polish 806 bytes
2024-01-24 17:56
Lista akcjonariuszy, którzy wzięli udział w Walnym Zgromadzeniu oraz mieli co n…
Polish 810 bytes
2024-01-18 08:46
Otrzymanie pisma z Instytutu Weterynaryjnego - Państwowego Instytutu Badawczego…
Polish 874 bytes
2024-01-02 17:24
Wygaśnięcie umowy o zachowaniu poufności - Content (PL)
Polish 654 bytes
2023-12-28 17:28
Formularz dla pełnomocnika
Polish 133.8 KB
2023-12-28 17:28
Proponowane zmiany statutu Labocanna S.A.
Polish 183.6 KB
2023-12-28 17:28
Projekty uchwał na NWZA Labocanna S.A.
Polish 221.4 KB
2023-12-28 17:28
Ogłoszenie o NWZA Labocanna S.A.
Polish 99.3 KB
2023-12-28 17:28
ogłoszenie o zwołaniu NWZ na dzień 24 stycznia 2024 r. wraz z projektami uchwał…
Polish 469 bytes
2023-12-28 16:49
Lista akcjonariuszy, którzy wzięli udział w Walnym Zgromadzeniu oraz mieli co n…
Polish 603 bytes
2023-12-20 18:02
Założenie spółki zależnej - Content (PL)
Polish 1.0 KB
2023-12-01 15:37
Formularz dla pełnomocnika na NWZA
Polish 132.6 KB
2023-12-01 15:37
Proponowane zmiany statutu na NWZA
Polish 204.9 KB
2023-12-01 15:37
Projekty uchwła na NWZA
Polish 246.8 KB

Automate Your Workflow. Get a real-time feed of all Labocanna Spolka Akcyjna filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Labocanna Spolka Akcyjna

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Labocanna Spolka Akcyjna via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures in vitro diagnostic solutions for infectious diseases.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
A late-stage pharmaceutical company developing a treatment for nicotine dependence.
United States of America
ACHV
AC Immune SA Logo
Biopharmaceutical firm developing precision medicine for neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
Clinical-stage biopharmaceutical company developing drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Clinical-stage biopharma using proteomics to develop precision oncology therapies.
United States of America
ACRV
Acticor Biotech Logo
Develops treatments for thrombotic diseases, focusing on acute ischemic stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Clinical-stage company developing targeted radiotherapies for difficult-to-treat cancers.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing therapies for cancers with high unmet needs.
United States of America
ACTU
AcuCort AB Logo
Develops user-friendly drug formulations for severe and acute allergic reactions.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted therapies for Alzheimer's disease.
United States of America
ABOS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.